nach oben

NeuroMolecular Medicine

Erschienen in:

23.05.2017 | Review Paper

Models for Studying Myelination, Demyelination and Remyelination

verfasst von: I. Osorio-Querejeta, M. Sáenz-Cuesta, M. Muñoz-Culla, D. Otaegui

Erschienen in: NeuroMolecular Medicine | Ausgabe 2-3/2017

Einloggen, um Zugang zu erhalten

Abstract

One of the most widely studied demyelinating diseases is multiple sclerosis, which is characterised by the appearance of demyelinating plaques, followed by myelin regeneration. Nevertheless, with disease progression, remyelination tends to fail, increasing the characteristic neurodegeneration of the disease. It is essential to understand the mechanisms that operate in the processes of myelination, demyelination and remyelination to develop treatments that promote the production of new myelin, thereby protecting the central nervous system. A huge variety of models have been developed to help improve our understanding of these processes. Nevertheless, no single model allows us to study all the processes involved in remyelination and usually more than one is needed to provide a full picture of related mechanisms. In this review, we summarise the most commonly used models for studying myelination, demyelination and remyelination and we analyse them critically to outline the most suitable ways of using them.

Acs, P., & Kalman, B. (2012). Pathogenesis of multiple sclerosis: What can we learn from the cuprizone model. Methods in Molecular Biology, 900, 403–431. doi:10.1007/978-1-60761-720-4_20.CrossRefPubMed

Allt, G., Ghabriel, M. N., & Sikri, K. (1988). Lysophosphatidyl choline-induced demyelination. A freeze-fracture study. Acta neuropathologica, 75(5), 456–64. http://www.ncbi.nlm.nih.gov/pubmed/3376751.

Babri, S., Mehrvash, F., Mohaddes, G., Hatami, H., & Mirzaie, F. (2015). Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats, 5(1), 83–87. doi:10.5681/apb.2015.011.

Baker, D., & Amor, S. (2015). Mouse models of multiple sclerosis: Lost in translation? Current Pharmaceutical Design, 21, 2440–2452.CrossRefPubMed

Bando, Y., Takakusaki, K., Ito, S., Terayama, R., Kashiwayanagi, M., & Yoshida, S. (2008). Differential changes in axonal conduction following CNS demyelination in two mouse models. European Journal of Neuroscience, 28(9), 1731–1742. doi:10.1111/j.1460-9568.2008.06474.x.CrossRefPubMed

Baxi, E. G., DeBruin, J., Tosi, D. M., Grishkan, I. V., Smith, M. D., Kirby, L. A., et al. (2015). Transfer of myelin-reactive Th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. Journal of Neuroscience, 35(22), 8626–8639. doi:10.1523/JNEUROSCI.3817-14.2015.CrossRefPubMedPubMedCentral

Ben-Hur, T. (2011). Cell therapy for multiple sclerosis. Neurotherapeutics The journal of the American Society for Experimental NeuroTherapeutics, 8(4), 625–642. doi:10.1007/s13311-011-0073-x.CrossRefPubMedPubMedCentral

Birgbauer, E., Rao, T. S., & Webb, M. (2004). Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. Journal of Neuroscience Research, 78(September), 157–166. doi:10.1002/jnr.20248.CrossRefPubMed

Bondan, E. F., Custódio, P. R., Lallo, M. A., Bentubo, H. D. L., & Graça, D. L. (2009). Ethidium bromide-induced demyelination in the sciatic nerve of diabetic rats. Arquivos de Neuro-Psiquiatria, 67(4), 1066–1070. doi:10.1590/S0004-282X2009000600020.CrossRefPubMed

Bornstein, M. B., & Appel, S. H. (1959). Demyelination in cultures of rat cerebellum produced by experimental allergic encephalomyelitic serum. Transactions of the American Neurological Association, 84, 165–6. http://www.ncbi.nlm.nih.gov/pubmed/13802908.

Brüstle, O., Jones, K. N., Learish, R. D., Karram, K., Choudhary, K., Wiestler, O. D., et al. (1999). Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science, 285(5428), 754–756. doi:10.1126/science.285.5428.754.CrossRefPubMed

Buckley, C. E., Goldsmith, P., & Franklin, R. J. (2008). Zebrafish myelination: a transparent model for remyelination? Disease Model Mechanism, 1(4–5), 221–228. doi:10.1242/dmm.001248.CrossRef

Buckley, C. E., Marguerie, A., Roach, A. G., Goldsmith, P., Fleming, A., Alderton, W. K., et al. (2010). Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology, 59(3), 149–159. doi:10.1016/j.neuropharm.2010.04.014.CrossRefPubMed

Bullock, P. N., & Rome, L. H. (1990). Glass micro-fibers: A model system for study of early events in myelination. Journal of Neuroscience Research, 27(3), 383–393. doi:10.1002/jnr.490270317.CrossRefPubMed

Callizot, N., Combes, M., Steinschneider, R., & Poindron, P. (2011). A new long term in vitro model of myelination. Experimental Cell Research, 317(16), 2374–2383. doi:10.1016/j.yexcr.2011.07.002.CrossRefPubMed

Chan, J. R., Watkins, T. A., Cosgaya, J. M., Zhang, C., Chen, L., Reichardt, L. F., et al. (2004). NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron, 43(2), 183–191. doi:10.1016/j.neuron.2004.06.024.CrossRefPubMedPubMedCentral

Chen, Y., Balasubramaniyan, V., Peng, J., Hurlock, E. C., Tallquist, M., Li, J., et al. (2007). Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nature Protocols, 2(5), 1044–1051. doi:10.1038/nprot.2007.149.CrossRefPubMed

Chen, Z., Ma, Z., Wang, Y., Li, Y., Lü, H., Fu, S., et al. (2010). Oligodendrocyte-spinal cord explant co-culture: An in vitro model for the study of myelination. Brain Research, 1309, 9–18. doi:10.1016/j.brainres.2009.10.060.CrossRefPubMed

Chomiak, T., & Hu, B. (2009). What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach. PLoS ONE, 4(11), e7754. doi:10.1371/journal.pone.0007754.CrossRefPubMedPubMedCentral

Chung, A. Y., Kim, P. S., Kim, S., Kim, E., Kim, D., Jeong, I., et al. (2013). Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS. Molecules and Cells, 36(1), 82–87. doi:10.1007/s10059-013-0087-9.CrossRefPubMedPubMedCentral

Constantinescu, C. S., Farooqi, N., O’Brien, K., & Gran, B. (2011). Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology, 164(4), 1079–1106. doi:10.1111/j.1476-5381.2011.01302.x.CrossRefPubMedPubMedCentral

Daviaud, N., Garbayo, E., Schiller, P. C., Perez-Pinzon, M., & Montero-Menei, C. N. (2013). Organotypic cultures as tools for optimizing central nervous system cell therapies. Experimental Neurology, 248, 429–440. doi:10.1016/j.expneurol.2013.07.012.CrossRefPubMed

Diao, H. J., Low, W. C., Lu, Q. R., & Chew, S. Y. (2015a). Topographical effects on fiber-mediated microRNA delivery to control oligodendroglial precursor cells development. Biomaterials, 70, 105–114. doi:10.1016/j.biomaterials.2015.08.029.CrossRefPubMedPubMedCentral

Diao, H. J., Low, W. C., Milbreta, U., Lu, Q. R., & Chew, S. Y. (2015b). Nanofiber-mediated microRNA delivery to enhance differentiation and maturation of oligodendroglial precursor cells. Journal of Controlled Release. doi:10.1016/j.jconrel.2015.03.005.PubMedPubMedCentral

Dincman, T. A., Beare, J. E., Ohri, S. S., & Whittemore, S. R. (2012). Isolation of cortical mouse oligodendrocyte precursor cells. Journal of Neuroscience Methods, 209(1), 219–226. doi:10.1016/j.jneumeth.2012.06.017.CrossRefPubMedPubMedCentral

Dousset, V., Brochet, B., Vital, A., Gross, C., Benazzouz, A., Boullerne, A., et al. (1995). Lysolecithin-induced demyelination in primates: Preliminary in vivo study with MR and magnetization transfer. American Journal of Neuroradiology, 16(2), 225–231.PubMed

Dubois-Dalcq, M., Williams, A., Stadelmann, C., Stankoff, B., Zalc, B., & Lubetzki, C. (2008). From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases. Brain A Journal of Neurology, 131, 1686–1700. doi:10.1093/brain/awn076.CrossRefPubMedPubMedCentral

Dugas, J. C., & Emery, B. (2013). Purification of oligodendrocyte precursor cells from rat cortices by immunopanning. Cold Spring Harbor protocols, 2013(8), 745–758. doi:10.1101/pdb.prot070862.CrossRefPubMed

Dugas, J. C., Tai, Y. C., Speed, T. P., Ngai, J., & Barres, B. A. (2006). Functional genomic analysis of oligodendrocyte differentiation. The Journal of Neuroscience, 26(43), 10967–10983. doi:10.1523/JNEUROSCI.2572-06.2006.CrossRefPubMed

Ffrench-Constant, C., & Raff, M. C. (1986). Proliferating bipotential glial progenitor cells in adult rat optic nerve. Nature, 319(6053), 499–502. doi:10.1038/319499a0.CrossRefPubMed

Fleming, K. K., Bovaird, J. A., Mosier, M. C., Emerson, M. R., LeVine, S. M., & Marquis, J. G. (2005). Statistical analysis of data from studies on experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 170, 71–84. doi:10.1016/j.jneuroim.2005.08.020.CrossRefPubMed

Franklin, R. J. M. (2002). Why does remyelination fail in multiple sclerosis? Nature Reviews Neuroscience, 3(9), 705–714. doi:10.1038/nrn917.CrossRefPubMed

Gensert, J. M., & Goldman, J. E. (1997). Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron, 19(1), 197–203. doi:10.1016/S0896-6273(00)80359-1.CrossRefPubMed

Goudarzvand, M., Javan, M., Mirnajafi-Zadeh, J., Mozafari, S., & Tiraihi, T. (2010). Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide. Cellular and Molecular Neurobiology, 30(2), 289–299. doi:10.1007/s10571-009-9451-x.CrossRefPubMed

Hedvika, D., Gonzalez, M., Bhargava, N., Stancescu, M., Hickman, J. J., & Lambert, S. (2012). Rat costical oligodendrocyte-embryonic motoneuron co-culture: An in vitro axon-oilgodendrocyte interaction model. Journal of Biomaterials Tissue Engineering, 2(3), 206–214.CrossRef

Hohlfeld, R. (2009). Multiple sclerosis: Human model for EAE? European Journal of Immunology, 39(8), 2036–2039. doi:10.1002/eji.200939545.CrossRefPubMed

Howe, C. L. (2006). Coated glass and vicryl microfibers as artificial axons. Cells Tissues Organs, 183(4), 180–194. doi:10.1159/000096509.CrossRefPubMed

Hyung, S., Yoon Lee, B., Park, J.-C., Kim, J., Hur, E.-M., & Francis Suh, J.-K. (2015). Coculture of primary motor neurons and schwann cells as a model for in vitro myelination. Scientific Reports, 5, 15122. doi:10.1038/srep15122.CrossRefPubMedPubMedCentral

Jung, S. H., Kim, S., Chung, A. Y., Kim, H. T., So, J. H., Ryu, J., et al. (2010). Visualization of myelination in GFP-transgenic zebrafish. Developmental Dynamics, 239(2), 592–597. doi:10.1002/dvdy.22166.CrossRefPubMed

Keough, M. B., Jensen, S. K., & Yong, V. W. (2015). Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin. Journal of Visualized Experiments, 97, 10–17. doi:10.3791/52679.

Kim, S., Chung, A.-Y., Kim, D., Kim, Y.-S., Kim, H.-S., Kwon, H.-W., et al. (2011). Tcf3 function is required for the inhibition of oligodendroglial fate specification in the spinal cord of zebrafish embryos. Molecules and Cells, 32(4), 383–388. doi:10.1007/s10059-011-0152-1.CrossRefPubMedPubMedCentral

Kipp, M., Clarner, T., Dang, J., Copray, S., & Beyer, C. (2009). The cuprizone animal model: New insights into an old story. Acta Neuropathologica, 118(6), 723–736. doi:10.1007/s00401-009-0591-3.CrossRefPubMed

Kipp, M., van der Star, B., Vogel, D. Y. S., Puentes, F., van der Valk, P., Baker, D., et al. (2012). Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond. Multiple Sclerosis and Related Disorders, 1, 15–28. doi:10.1016/j.msard.2011.09.002.CrossRefPubMed

Kirby, B. B., Takada, N., Latimer, A. J., Shin, J., Carney, T. J., Kelsh, R. N., et al. (2006). In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nature Neuroscience, 9(12), 1506–1511. doi:10.1038/nn1803.CrossRefPubMed

Kurtzberg, J. (2011). Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood, 13(6), 722–729. doi:10.3109/14653249.2011.553592.Isolation.

Kuypers, N. J., James, K. T., Enzmann, G. U., Magnuson, D. S. K., & Whittemore, S. R. (2013). Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Experimental Neurology, 247, 615–622. doi:10.1016/j.expneurol.2013.02.014.CrossRefPubMedPubMedCentral

Lee, S., Chong, S. Y., Tuck, S. J., Corey, J. M., & Chan, J. R. (2013). A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers. Nature Protocols, 8(4), 771–782. http://www.ncbi.nlm.nih.gov/pubmed/23589937.

Lee, S., Leach, M. K., Redmond, S. A., Chong, S. Y. C., Mellon, H., Tuck, S. J., et al. (2012). A culture system to study oligodendrocyte myelination-processes using engineered nanofibers. Nature Methods, 9(9), 917–922. doi:10.1038/nmeth.2105.A.CrossRefPubMedPubMedCentral

Lorentzen, J. C., Issazadeh, S., Storch, M., Mustafa, M. I., Lassman, H., Linington, C., et al. (1995). Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund’s adjuvant. Journal of Neuroimmunology, 63(2), 193–205. doi:10.1016/0165-5728(95)00153-0.CrossRefPubMed

Magalon, K., Cantarella, C., Monti, G., Cayre, M., & Durbec, P. (2007). Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models. European Journal of Neuroscience, 25(3), 761–771. doi:10.1111/j.1460-9568.2007.05335.x.CrossRefPubMed

Medina-Rodríguez, E. M., Arenzana, F. J., Bribián, A., & de Castro, F. (2013). Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans. PLoS ONE. doi:10.1371/journal.pone.0081620.PubMedPubMedCentral

Meffre, D., Shackleford, G., Hichor, M., Gorgievski, V., Tzavara, E. T., Trousson, A., et al. (2015). Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum. Proceedings of the National Academy of Sciences, 8(3), 201424951. doi:10.1073/pnas.1424951112.

Mei, F., Fancy, S. P. J., Shen, Y. A., Niu, J., Zhao, C., Presley, B., et al. (2014). Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nature Medicine, 20(8), 954–960. doi:10.1038/nm.3618.CrossRefPubMedPubMedCentral

Mendel, I., de Rosbo, N. K., & Ben-Nun, A. (1995). A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. European Journal of Immunology, 25(7), 1951–1959. doi:10.1002/eji.1830250723.CrossRefPubMed

Merrill, J. E. (2009). In vitro and in vivo pharmacological models to assess demyelination and remyelination. Neuropsychopharmacology, 34(1), 55–73. doi:10.1038/npp.2008.145.CrossRefPubMed

Miller, R. H., & Fyffe-Maricich, S. L. (2010). Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models. Disease Models and Mechanisms, 3(9–10), 535–539. doi:10.1242/dmm.001958.CrossRefPubMedPubMedCentral

Miron, V. E., Kuhlmann, T., & Antel, J. P. (2011). Cells of the oligodendroglial lineage, myelination, and remyelination. Biochimica et Biophysica Acta, 1812(2), 184–193. doi:10.1016/j.bbadis.2010.09.010.CrossRefPubMed

Monaco, M. C. G., Maric, D., Bandeian, A., Leibovitch, E., Yang, W., & Major, E. O. (2012). Progenitor-derived oligodendrocyte culture system from human fetal brain. Journal of Visualized Experiments JoVE. doi:10.3791/4274.PubMedPubMedCentral

Moreno, B., Espejo, C., Mestre, L., Suardiaz, M., Clemente, D., de Castro, F., et al. (2012). Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis. Revista d Neurologia, 54(2), 114–124. http://www.ncbi.nlm.nih.gov/pubmed/22234570.

Nastasijevic, B., Wright, B. R., Smestad, J., Warrington, A. E., Rodriguez, M., & Maher, L. J. (2012). Remyelination induced by a DNA Aptamer in a mouse model of multiple sclerosis. PLoS ONE, 7(6), 1–8. doi:10.1371/journal.pone.0039595.CrossRef

Nishimura, R. N., Blank, N. K., Tiekotter, K. L., Cole, R., & De Vellis, J. (1985). Myelination of mouse cerebellar explants by rat cultured oligodendrocytes. Brain Research, 337(1), 159–162. doi:10.1016/0006-8993(85)91623-3.CrossRefPubMed

Ogawa, S., Tokumoto, Y., Miyake, J., & Nagamune, T. (2011). Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes. Neuroscience Letters. doi:10.1016/j.neulet.2010.11.070.PubMed

Oskari Virtanen, J., & Jacobson, S. (2012). Viruses and multiple sclerosis. Current Drug Targets: CNS & Neurological Disorders, 11(5), 528–544.

Päiväläinen, S., Nissinen, M., Honkanen, H., Lahti, O., Kangas, S. M., Peltonen, J., et al. (2008). Myelination in mouse dorsal root ganglion/Schwann cell cocultures. Molecular and Cellular Neuroscience, 37(3), 568–578. doi:10.1016/j.mcn.2007.12.005.CrossRefPubMed

Pang, Y., Zheng, B., Kimberly, S. L., Cai, Z., Rhodes, P. G., & Lin, R. C. S. (2012). Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex. Brain and Behavior, 2(1), 53–67. doi:10.1002/brb3.33.CrossRefPubMedPubMedCentral

Pesheva, P. (2006). Method for isolating neural cells using tenascin-r compounds. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2006067094.

Rassul, S. M., Neely, R. K., & Fulton, D. (2016). Live-imaging in the CNS: New insights on oligodendrocytes, myelination, and their responses to inflammation. Neuropharmacology, 110, 594–604. doi:10.1016/j.neuropharm.2015.09.011.CrossRefPubMed

Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933). Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. The Journal of Experimental Medicine, 58(1), 39–53. doi:10.1084/jem.58.1.39.CrossRefPubMedPubMedCentral

Robinson, A. P., Rodgers, J. M., Goings, G. E., & Miller, S. D. (2014). Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis. PLoS ONE, 9(9), e107649. doi:10.1371/journal.pone.0107649.CrossRefPubMedPubMedCentral

Rodriguez, M. (2003). A function of myelin is to protect axons from subsequent injury: Implications for deficits in multiple sclerosis. Brain, 126(4), 751–752. doi:10.1093/brain/awg070.CrossRefPubMed

Rosenberg, S. S., Kelland, E. E., Tokar, E., De la Torre, A. R., & Chan, J. R. (2008). The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proceedings of the National Academy of Sciences of the United States of America, 105(38), 14662–14667. doi:10.1073/pnas.0805640105.CrossRefPubMedPubMedCentral

Sachs, H. H., Bercury, K. K., Popescu, D. C., Narayanan, S. P., & Macklin, W. B. (2014). A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro. doi:10.1177/1759091414551955.PubMedPubMedCentral

Schnädelbach, O., Ozen, I., Blaschuk, O. W., Meyer, R. L., & Fawcett, J. W. (2001). N-cadherin is involved in axon-oligodendrocyte contact and myelination. Molecular and cellular neurosciences, 17(6), 1084–1093. doi:10.1006/mcne.2001.0961.CrossRefPubMed

Shi, J., Marinovich, A., & Barres, B. A. (1998). Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. The Journal of Nuroscience, 18(12), 4627–4636.

Smithburn, K. C., Haddow, A. J., & Mahaffy, A. F. (1946). A neurotropic virus isolated from Aedes mosquitoes caught in the Semliki forest. The American Journal of Tropical Medicine and Hygiene, 26, 189–208. http://www.ncbi.nlm.nih.gov/pubmed/21020339.

van der Star, B. J., Vogel, D. Y. S., Kipp, M., Puentes, F., Baker, D., Amor, S. (2012). In Vitro and In Vivo Models of Multiple Sclerosis. CNS & Neurological Disorders: Drug Targets. doi:10.2174/187152712801661284.

Steinman, L. (2003). Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. The Journal of Experimental Medicine, 197(9), 1065–1071. doi:10.1084/jem.20030320.CrossRefPubMedPubMedCentral

Steinman, L., & Zamvil, S. S. (2005). Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends in Immunology.. doi:10.1016/j.it.2005.08.014.PubMed

Sun, X., Liu, Y., Liu, B., Xiao, Z., & Zhang, L. (2012). Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse. Experimental Neurology, 237(2), 304–311. doi:10.1016/j.expneurol.2012.07.011.CrossRefPubMed

Syed, Y. A., Baer, A., Hofer, M. P., González, G. A., Rundle, J., Myrta, S., et al. (2013). Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. EMBO Molecular Medicine, 5(12), 1918–1934. doi:10.1002/emmm.201303123.CrossRefPubMedPubMedCentral

Theiler, M. (1934). Spontaneous encephalomyelitis of mice. A new virus disease. Science, 80(2066), 122. doi:10.1126/science.80.2066.122-a.CrossRefPubMed

Thomson, C. E., Hunter, A. M., Griffiths, I. R., Edgar, J. M., & McCulloch, M. C. (2006). Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats. Journal of Neuroscience Research, 84(11), 1703–1715. doi:10.1002/jnr.CrossRefPubMed

Torkildsen, O., Brunborg, L. A., Myhr, K. M., Bo, L., Torkildsen, Ø., La, B., et al. (2008). The cuprizone model for demyelination. Acta Neurologica Scandinavica. Supplementum, 188(4), 72–76. doi:10.1111/j.1600-0404.2008.01036.x.CrossRefPubMed

Vereyken, E. J. F., Fluitsma, D. M., Bolijn, M. J., Dijkstra, C. D., & Teunissen, C. E. (2009). An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures. Glia, 57(12), 1326–1340. doi:10.1002/glia.20852.CrossRefPubMed

Watanabe, M., Toyama, Y., & Nishiyama, A. (2002). Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. Journal of Neuroscience Research, 69(6), 826–836. doi:10.1002/jnr.10338.CrossRefPubMed

Watkins, T. A., Emery, B., Mulinyawe, S., & Barres, B. A. (2008). Distinct stages of myelination regulated by γ-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron, 60(4), 555–569. doi:10.1016/j.neuron.2008.09.011.CrossRefPubMedPubMedCentral

Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proceedings of the National Academy of Sciences, 105(15), 5856–5861. doi:10.1073/pnas.0801677105.CrossRef

Zamvil, S. S., Mitchell, D. J., Moore, A. C., Kitamura, K., Steinman, L., & Rothbard, J. B. (1986). T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature, 324(6094), 258–260. doi:10.1038/324258a0.CrossRefPubMed

Zhang, H., Jarjour, A. A., Boyd, A., & Williams, A. (2011). Central nervous system remyelination in culture—a tool for multiple sclerosis research. Experimental Neurology, 230(1), 138–148. doi:10.1016/j.expneurol.2011.04.009.CrossRefPubMedPubMedCentral

Titel: Models for Studying Myelination, Demyelination and Remyelination
verfasst von: I. Osorio-Querejeta
M. Sáenz-Cuesta
M. Muñoz-Culla
D. Otaegui
Publikationsdatum: 23.05.2017
Verlag: Springer US
Erschienen in: NeuroMolecular Medicine / Ausgabe 2-3/2017
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-017-8442-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Models for Studying Myelination, Demyelination and Remyelination

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2-3/2017

Transgenic Mice Overexpressing the Divalent Metal Transporter 1 Exhibit Iron Accumulation and Enhanced Parkin Expression in the Brain

Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine–Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats

Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis

Vitamin D3 Reverses the Hippocampal Cytoskeleton Imbalance But Not Memory Deficits Caused by Ovariectomy in Adult Wistar Rats

Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB

rs3851179 Polymorphism at 5′ to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie